The AEterna Zentaris Inc. (AEZS) Sees Unusually-High Trading Volume on Analyst Upgrade

The AEterna Zentaris Inc. (AEZS) Sees Unusually-High Trading Volume on Analyst Upgrade

AEterna Zentaris Inc. (NASDAQ:AEZS) (TSE:AEZ) shares saw unusually-high trading volume on Tuesday after Maxim Group raised their price target on the stock from $7.00 to $10.00. Maxim Group currently has a buy rating on the stock. Approximately 784,471 shares traded hands during mid-day trading, an increase of 67% from the previous session’s volume of 470,075 shares.The stock last traded at $2.90 and had previously closed at $2.55.

Several other analysts also recently commented on AEZS. HC Wainwright reaffirmed a “buy” rating and set a $7.50 price objective (down from $12.00) on shares of AEterna Zentaris in a research note on Tuesday, January 10th. Zacks Investment Research raised AEterna Zentaris from a “sell” rating to a “buy” rating and set a $3.00 price objective for the company in a research note on Tuesday, January 10th. Finally, Canaccord Genuity set a $6.00 price objective on AEterna Zentaris and gave the company a “buy” rating in a research note on Sunday, January 8th.

The company’s 50 day moving average is $3.43 and its 200-day moving average is $3.55. The company’s market capitalization is $31.51 million.

About AEterna Zentaris

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women’s health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others.

Related posts

Leave a Comment